{
    "root": "d1852462-1abc-4acb-8239-db0de7a42d7e",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Mometasone Furoate",
    "value": "20250325",
    "ingredients": [
        {
            "name": "PETROLATUM",
            "code": "4T6H12BN9U"
        },
        {
            "name": "WHITE WAX",
            "code": "7G1J5DA97F"
        },
        {
            "name": "PROPYLENE GLYCOL STEARATE",
            "code": "MZM1I680W0"
        },
        {
            "name": "HEXYLENE GLYCOL",
            "code": "KEH0A3F75J"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "PHOSPHORIC ACID",
            "code": "E4GA8884NN"
        },
        {
            "name": "MOMETASONE FUROATE",
            "code": "04201GDN4R"
        }
    ],
    "indications": "mometasone furoate ointment corticosteroid indicated relief inflammatory pruritic manifestations corticosteroid-responsive dermatoses patients ≥ 2 years age ( 1 )",
    "contraindications": "apply thin film affected skin areas daily . ( 2 ) discontinue therapy control achieved . ( 2 ) improvement seen within 2 weeks , reassess diagnosis . ( 2 ) occlusive dressings unless directed physician . ( 2 )",
    "warningsAndPrecautions": "mometasone furoate ointment usp white off-white uniform ointment supplied 15-gram ( ndc 13668-527-01 ) 45-gram ( ndc 13668-527-04 ) tubes ; boxes one . store 25°c ( 77°f ) ; excursions permitted 15° 30°c ( 59° 86°f ) [ usp controlled room temperature ] .",
    "adverseReactions": "mometasone furoate ointment contraindicated patients history hypersensitivity components preparation . ( 4 )",
    "indications_original": "Mometasone Furoate Ointment is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients ≥ 2 years of age ( 1 )",
    "contraindications_original": "Apply a thin film to the affected skin areas once daily. (2) Discontinue therapy when control is achieved. (2) If no improvement is seen within 2 weeks, reassess diagnosis. (2) Do not use with occlusive dressings unless directed by a physician. (2)",
    "warningsAndPrecautions_original": "Mometasone Furoate Ointment USP is a white to off-white uniform ointment and supplied in 15-gram (NDC 13668-527-01) and 45-gram (NDC 13668-527-04) tubes; boxes of one.\n                  Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Mometasone Furoate Ointment is contraindicated in those patients with a history of hypersensitivity to any of the components in the preparation. ( 4 )"
}